Effect of Cnidium Lactone on Serum Mutant P53 and BCL-2/BAX Expression in Human Prostate Cancer Cells PC-3 Tumor-Bearing BALB/C Nude Mouse Model

Abstract

BackgroundCnidium lactone is a natural coumarin compound that can inhibit a variety of cancer cell proliferation and induce cancer cell apoptosis. This experiment investigated the effect of cnidium lactone on molecular marker expression in prostate cancer nude mice to study its effect in inducing apoptosis.Material/MethodsWe randomly and equally divided 30 male BALB/C nude mice inoculated with human prostate cancer cells PC-3 into a negative control group, a cyclophosphamide group (500 mg/Kg), and cnidium lactone groups at 3 doses (280 mg/Kg, 140 mg/Kg, and 70 mg/Kg). The mice were weighed at 2 weeks after administration. Tunnel assay was applied to test the nude mice tumor cell apoptosis. ELISA was performed to detect serum AMACR, CD147, mutant P53, BCL-2, AND BAX expression levels. Tumor tissue was separated and weighed.ResultsMice weight did not change significantly in the groups receiving 3 different doses of cnidium lactone(p>0.05), while it decreased obviously in the cyclophosphamide group (p<0.05). Tumor weight, CD147, mutant P53, and BCL-2 levels were significantly lower in the groups receiving 3 different doses of cnidium lactone than in the negative control group (p<0.05). Among them, the abovementioned indexes decreased markedly in the 280 mg/Kg and 140 mg/Kg dose groups than in the cyclophosphamide group (p<0.05). AMACR and BAX levels showed no significant difference in the cnidium lactone group or the cyclophosphamide group (p>0.05).ConclusionsCnidium lactone may induce prostate cancer cell apoptosis and inhibit its proliferation through regulating CD147, mutant P53, and BCL-2 expression in nude mice.

Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity

“…4e, j ). In the Bcl-2 protein family, the Bcl-2/Bax ratio has been shown to affect apoptosis induction [ 26 , 27 ]. Our data indicated that USP37#2 shRNA combined with cisplatin induced the cell apoptosis with an underlying decrease in the Bcl-2/Bax ratio.…”

Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells

“…One of the major determinants of cell survival is the balance between the anti-apoptotic and pro-apoptotic members of the Bcl-2 family [18]. In the Bcl-2 protein family, pro-apoptotic factor Bax and anti-apoptotic factor Bcl-2 are the active regulators and effectors, and the ratio between Bcl-2 and Bax (Bcl-2/Bax) affects apoptosis induction [19,20]. In the meantime, we evaluated Bcl-2 and Bax after HMGB3 knockdown and found that Bax increased and Bcl-2 reduced when compared with the control group.…”

Induction Effect to Apoptosis by Maitake Polysaccharide: Synergistic Effect of Its Combination With Vitamin C in Neuroglioma Cell

“…The overexpression of Bcl-2 and inhibition of Bax expression are closely correlated with anti-apoptosis/apoptosis imbalance of glioma cells. 23 This study demonstrated that after MP/VC treatment, the proliferation of glioma cells was remarkably inhibited, enhancing tumor cell apoptosis, decreasing mRNA/protein expression of Bcl-2 while increasing Bax mRNA or protein expression. Meanwhile, the expression of caspase-3 and its endogenous substrate, cleavage of PARP, were enhanced in our study.…”